Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
A Certificate of Analysis (COA) is a document issued by a manufacturer or supplier’s quality control laboratory that reports the actual test results obtained for a specific batch or lot of a material, and confirms those results meet the material’s stated specification before that lot is released for use. It is a lot-specific quality record, not a generic product datasheet: a COA for lot 4471 of a reagent describes only lot 4471, and a new lot requires a new COA. For procurement and QA staff receiving reagents, raw materials, calibration standards, or active ingredients, the COA is the primary evidence a supplier provides that a given shipment actually is what it was ordered as.
This guide covers what a COA must contain to be usable, how to check one against the material it accompanies, and — the part most incoming-inspection SOPs get wrong — why a supplier’s COA, however complete, is rarely sufficient on its own in a GMP or accredited-testing environment.
What Does COA Stand For?
COA most often stands for Certificate of Analysis: a lot-specific quality document in which a manufacturer’s or supplier’s laboratory reports the test results for one batch against its specification. The same three letters have other meanings outside the lab, so the context decides which one applies. In Indonesian, “COA adalah” is usually answered the same way: a Certificate of Analysis is the document that records the test results for a production lot.
| Context | COA stands for | What it is |
|---|---|---|
| Laboratory, pharma, chemicals, food, supplements | Certificate of Analysis | Lot-specific test results against specification, covered in the rest of this guide |
| Accounting | Chart of Accounts | A structured list of the accounts a company uses to record transactions, which underpins its general ledger (definition) |
| Ophthalmology | Certified Ophthalmic Assistant | A certification offered by the International Joint Commission on Allied Health Personnel in Ophthalmology (IJCAHPO) |
| Finance and shipping | Cost of Acquisition; Carriage on Account | Less common business-term expansions listed in the same reference |
A COA is sometimes confused with a certificate that states only conformity. The difference, and why a compliant-looking certificate may still need checking, is covered in the sections below and in the guide to the certificate of conformity for medical devices.
What Is a Certificate of Analysis (COA) For?
A COA exists to transfer quality information from the party that tested a material to the party that will use it, without the receiving lab having to re-run every test itself. It typically accompanies chemicals, reagents, active pharmaceutical ingredients (APIs), reference standards, biological materials, and manufactured components at the point of shipment. The issuing lab — usually the manufacturer’s own QC unit, sometimes a contract or third-party testing lab — lists the specification for each tested parameter (an acceptable range, limit, or identity criterion) alongside the actual result obtained for that specific lot, and states whether the lot conforms.
A COA is evidence of testing performed at the point of manufacture or release. It is not, by itself, evidence that the material still meets specification when it arrives, that the container wasn’t compromised in transit, or that the lot number on the paperwork matches the lot number on the container in front of you — all of which is why receiving inspection exists as a separate step (see “When a Supplier COA Is Not Enough” below).
What Fields Does a Usable COA Need to Include?
There’s no single universal COA template — format varies by supplier, industry, and material type — but a COA that’s actually usable for incoming-material qualification needs to include, at minimum:
- Manufacturer/supplier name and address — who tested and released the material.
- Product name and catalog/part number — unambiguous identification of what was ordered.
- Lot or batch number — the single most important field to cross-check; this is what ties the paper to the physical container.
- Manufacture date and expiration or retest date — when the lot was produced and how long the stated results remain valid.
- Each tested parameter, its specification, and the actual result — not just a pass/fail summary. A COA that states only “conforms to specification” without the underlying numeric or qualitative results for each parameter is materially weaker evidence than one that shows, for example, assay = 99.7% against a specification of 98.0–102.0%.
- Test method reference — the compendial method (USP, EP, ASTM, ISO) or in-house method used for each result, so the receiving lab can judge whether the method is appropriate and comparable to its own.
- Units for every quantitative result.
- An overall conformance statement (e.g., “meets specification” / “released”).
- Signature, name, and date of the authorized QC/QA reviewer who approved the lot for release — an unsigned or undated COA has no accountable approver behind it.
Chemical COAs commonly add a CAS number and purity/assay percentage; biological materials commonly add sterility, endotoxin, and identity (e.g., species/strain) results; calibration standards and reference materials commonly add traceability to a national metrology institute (e.g., NIST) and an assigned uncertainty value.
How Do You Read and Verify a COA?
Verifying a COA is a specific, repeatable checklist step in incoming inspection, not a glance to confirm a document exists:
- Match the lot number. Confirm the lot/batch number on the COA is identical to the lot number printed on the physical container’s label. A COA for the right product but the wrong lot is not valid evidence for the material in hand — this is the single most common COA-verification failure found in supplier audits.
- Check results against your own specification, not just the supplier’s pass/fail statement. Your specification and the supplier’s may not be identical; a result that satisfies the supplier’s internal spec can still fall outside what your process requires. Read the actual numbers.
- Confirm the test method is appropriate. If your process depends on a specific compendial method (e.g., a USP identity test) and the COA reports results from a different method, that’s a gap worth flagging, not assuming away.
- Check the expiration/retest date against your intended use window. A COA reporting results that were valid at release doesn’t extend the material’s shelf life indefinitely.
- Confirm signature and approval. An authorized-signatory field left blank, or a photocopied/reused signature block, is a red flag worth escalating.
- Use the supplier’s verification portal where one exists. Many manufacturers now let customers look up a COA by lot number directly on the supplier’s website (via a QR code on the container or a lot-lookup tool) — cross-checking the document you received against the supplier’s own system is a stronger control than trusting a PDF alone, since it catches altered or mismatched paperwork. For how many units to test and examine on receipt, see the guide to an incoming inspection sampling plan.
When Is a Supplier’s COA Not Enough?
Relying on a supplier’s COA without any independent verification is a recurring finding in FDA inspections and ISO/IEC 17025 and ISO 9001 audits (see GxP Compliance: What GLP, GCP, GMP, and GDP Actually Require for the broader framework), and for GMP-regulated manufacturers it isn’t optional to skip. Under 21 CFR Part 211 (current Good Manufacturing Practice for finished pharmaceuticals), Subpart E governs testing and approval of components — 21 CFR 211.84 governs what a manufacturer may accept from a supplier (a “report of analysis” for components, a “certificate of testing” for containers and closures), and the practical expectation is that a manufacturer cannot simply file an incoming COA and release the component on that basis alone. At minimum, the receiving firm is expected to perform at least one confirmatory identity test on each lot of a component, and may only reduce further testing and rely more heavily on a supplier’s COA where it has established, and periodically re-validates, the reliability of that supplier’s testing through documented supplier qualification (e.g., periodic on-site or remote audits, historical conformance data, and comparative testing; see Nonconformity: ISO Definition, Major vs. Minor, and the NCR/NCAR Process for how a failed verification should be handled).
ISO 9001:2015 builds in the same principle from the buyer’s side under its requirements for control of externally provided processes, products and services (clause 8.4): an organization has to define and apply criteria for verifying that purchased material meets requirements before use, and a COA is one input to that verification, not a substitute for it. ISO/IEC 17025-accredited testing laboratories face an equivalent expectation for any reference materials, reagents, or calibration standards they bring in and rely on for accredited test results — the same accreditation logic that underpins proficiency testing and external quality assessment — the accreditation body expects to see the lab’s own verification activity, not just a filed supplier certificate.
In practice, “not enough on its own” usually means one or more of the following, calibrated to the material’s risk and criticality: an identity confirmation test performed in-house, a documented supplier-qualification program that periodically audits or re-verifies the supplier’s own testing reliability, comparative or trend analysis of COA results across multiple lots from the same supplier, and a physical/visual inspection of the container and label against the COA on every receipt regardless of testing decisions.
How Does a COA Differ From Related Documents Like a CoC or SDS?
COAs are frequently confused with, or bundled alongside, several adjacent documents that serve different purposes:
- Certificate of Conformance (CoC) — a shorter statement that a lot meets its specification, typically without reporting the underlying test results. A CoC tells you the supplier says it passed; a COA shows you the numbers behind that claim. Where both are available, the COA is the stronger record for incoming inspection.
- Safety Data Sheet (SDS) — covers hazard, handling, and safety information for a chemical product generally; it is not lot-specific and does not report quality test results.
- Certificate of Origin — a customs/trade document confirming where a product was manufactured, used for import/export and tariff purposes, unrelated to quality testing.
What to Do When a COA Is Missing, Incomplete, or Fails
Incoming-inspection SOPs usually describe the happy path in detail and the failure path in a sentence. In practice the failure path is where the regulatory exposure sits, and 21 CFR Part 211 is unusually explicit about the starting point. Under 21 CFR 211.84(a), each lot of components, drug product containers and closures “shall be withheld from use until the lot has been sampled, tested, or examined, as appropriate, and released for use by the quality control unit.” Quarantine is the default state of received material, not a punishment applied after something goes wrong. Everything below is a variation on how a lot leaves quarantine, or does not.
The COA never arrived, or arrived for the wrong lot
Treat these identically, because a COA bearing a different lot number is not evidence about the material in front of you. The material stays in quarantine and is physically or systematically segregated so it cannot be drawn into use. Request the correct lot-specific document from the supplier, referencing the purchase order, the catalog number and the lot number printed on the container. Suppliers that operate a lot-lookup portal will often let you retrieve the document yourself against the lot number or the QR code on the label, which is the faster route and also the stronger control, because a document pulled from the supplier’s own system cannot be an altered PDF. Record the discrepancy in the receiving record whether or not it is resolved quickly – a pattern of missing or mismatched paperwork is exactly the trend a supplier-qualification review is supposed to catch.
The COA is present but incomplete
A document that states only “conforms to specification” with no per-parameter results, or that has an empty signature or date field, or that cites no test method, is not a usable release record even though a COA technically exists. Ask the supplier for the complete document rather than accepting the summary. If the supplier declines or cannot produce per-parameter data, that is a finding about the supplier, and it should feed the qualification decision rather than being absorbed silently by the receiving lab.
A result is out of specification
Distinguish two cases, because they have different consequences:
- The result is outside the supplier’s own specification. The lot should not have been released to you, and the reasonable step is to reject it and return it. Under 21 CFR 211.84(e), a lot that does not meet the appropriate written specifications of identity, strength, quality and purity “shall be rejected” – the regulation offers no discretion to accept a failing component because the schedule is tight.
- The result is inside the supplier’s specification but outside yours. This is the more common and more dangerous case, because the paperwork says “pass” and the material is nonetheless unsuitable for your process. It is a nonconformity against your own requirement, not against the supplier’s, and it needs to be raised and dispositioned as one rather than waved through on the strength of the supplier’s conformance statement.
Either way the disposition belongs in a documented nonconformance record with an owner and a decision – accept, reject, return, or use under a formally justified concession – not in an email thread. CASRAI’s guide to nonconformity and the NCR/NCAR process covers how that record should be structured. Where the receiving lab’s own confirmatory test disagrees with the supplier’s COA for the same parameter, that discrepancy is itself the finding: it calls the supplier’s testing reliability into question, which is the specific thing 211.84(d)(2) requires a manufacturer to have established before leaning on supplier data at all.
The verification burden the regulation actually imposes
It is worth reading the operative sentence rather than paraphrasing it. 21 CFR 211.84(d)(1) requires that “at least one test shall be conducted to verify the identity of each component of a drug product,” using specific identity tests where they exist. 211.84(d)(2) then sets the terms on which a supplier’s document can substitute for your own full testing: a report of analysis may be accepted from the supplier “provided that at least one specific identity test is conducted on such component by the manufacturer, and provided that the manufacturer establishes the reliability of the supplier’s analyses through appropriate validation of the supplier’s test results at appropriate intervals.”
Two obligations sit inside that sentence, and firms routinely satisfy the first while neglecting the second. The identity test on every lot is the visible one. The periodic re-validation of the supplier’s results – comparative testing, trend review across lots, audit – is the one that lapses quietly, and its absence is what converts a reasonable reliance on supplier data into an inspection finding. Containers and closures follow a parallel but lighter rule under 211.84(d)(3): a certificate of testing may be accepted from the supplier provided the manufacturer conducts at least a visual identification and likewise establishes the reliability of the supplier’s test results at appropriate intervals.
What Do the Regulations Let You Accept From a Supplier’s COA?
The rules differ by regime, and the data table below the article compares them side by side. In summary, every regime keeps some check in the receiver’s hands and allows a supplier certificate to stand in for the remaining testing only after the receiver has established that the supplier can be trusted.
Drug-product components and containers: 21 CFR 211.84
Paragraph (d)(1) requires at least one test to verify the identity of each component, using specific identity tests where they exist. Paragraph (d)(2) allows a supplier’s report of analysis to be accepted in place of the manufacturer’s own testing for purity, strength and quality, provided the manufacturer runs at least one specific identity test and establishes the reliability of the supplier’s analyses through appropriate validation at appropriate intervals. For containers and closures, (d)(3) accepts a supplier’s certificate of testing if the manufacturer performs at least a visual identification and validates the supplier’s results at appropriate intervals.
Dietary supplements: 21 CFR 111.75
For dietary-ingredient components the manufacturer must conduct at least one appropriate test to verify identity. For other components, a supplier’s certificate of analysis may be relied on if the supplier has first been qualified by confirming the reliability of its certificates, and the certificate includes a description of the test or examination methods, the limits, and the actual results. Qualification records must be kept, reliability periodically re-confirmed, and quality control must review and approve the basis for the qualification.
Active pharmaceutical ingredients: ICH Q7 section 7.3
ICH Q7 (hosted by FDA) expects at least one identity test per batch of incoming material, and allows a supplier’s certificate to replace other tests where the manufacturer has a system for evaluating suppliers. Supplier approval should rest on evidence such as past quality history, and the guidance calls for complete analyses on at least three batches before in-house testing is reduced, followed by complete analyses at appropriate intervals compared against the CoAs, with reliability checked at regular intervals. For processing aids, hazardous or highly toxic raw materials, other special materials and intra-company transfers, testing may be omitted when the manufacturer’s CoA is obtained, with visual examination of containers and labels and recording of batch numbers; the lack of testing must be justified and documented.
What Must a COA Contain Under ICH Q7?
Section 11.4 of ICH Q7 sets out CoA content for APIs and intermediates. An authentic certificate of analysis should be available for each batch on request. It should name the material including its grade, and give the batch number and release date. Expiry dates appear on the label and CoA, and retest dates on the label and/or CoA. Each test is listed per compendial or customer requirements with its acceptance limits and numerical results. The certificate is dated and signed by authorized quality-unit personnel and shows the name, address and telephone number of the original manufacturer.
Repackers, Brokers and Re-Issued Certificates
Material often changes hands before it reaches the user. ICH Q7 requires that where a repacker, reprocessor, agent or broker issues a new certificate, it shows the name, address and telephone number of the laboratory that performed the analysis, references the original manufacturer and the original batch certificate, and has a copy of that original certificate attached. The WHO model certificate of analysis follows the same principle: the original manufacturer is named, and where a repacker or trader is involved they are identified too. When you receive a re-issued certificate, a quick check is whether the original manufacturer’s certificate is attached and its batch number matches.
What Does the WHO Model Certificate of Analysis Include?
The WHO model (Technical Report Series annex 4) is written for quality control laboratories and is an example rather than a prescribed format; layout is at the issuing laboratory’s discretion. Its fields are:
- issuing laboratory name and address, and a certificate identifier with page x of y;
- requester, sample registration, date received and quantity;
- product name and description, batch number, expiry or retest date, and manufacture date;
- the original manufacturer (and any repacker or trader);
- the specification and the test procedure reference, including acceptance criteria;
- numerical results, with any subcontracted results identified;
- comments on test conditions, and a conclusion against the specification;
- date and signature of the head of laboratory or authorized person.
The model also says the sampling plan should be referenced where it matters to the validity of the result, that a statement of measurement uncertainty should be included where relevant or requested by the customer, and that laboratories accredited to ISO/IEC 17025 should reference the accreditation where it relates to the analysis. Trade certificates may state shipping or storage conditions whose breach invalidates the certificate.
Certificates for Reference Materials
A certificate of analysis for a reference material carries different weight from a routine lot certificate. NIST issues a Certificate of Analysis for a Standard Reference Material certified for one or more specific chemical properties. A certified value is one for which NIST has the highest confidence in its accuracy, with all known or suspected sources of bias investigated or accounted for. A non-certified value is a best estimate based on available information. From 1987 until July 2020 NIST called non-certified values “Reference Values” (with an uncertainty estimate) or “Information Values” (without one); for reference materials developed after July 2020 the accompanying document is a Reference Material Information Sheet, which contains no NIST certified values. When you read a reference-material certificate, use only the values labelled certified for calibration or trueness checks.
Worked Example: Reading an Incoming Excipient COA
This is an illustrative walkthrough of the checks above, not a real supplier. A manufacturer receives a drum of an excipient with a COA. First, it confirms the certificate shows the material name and grade, batch number, release and expiry or retest dates, tests with limits and numerical results, a signature, and the original manufacturer’s details. Second, it matches the batch number on the drum to the certificate. Third, it carries out its own identity test, which no regime allows it to skip. Fourth, it checks whether the supplier has been qualified: if not, it tests fully, and under ICH Q7 only after complete analyses on at least three batches that agree with the CoAs does it consider reducing in-house testing. If the drum came through a broker, it also checks that the original manufacturer’s certificate is attached.
Common Mistakes
- Treating a certificate of conformance as if it reported results; a COA must show numerical results against limits.
- Skipping the identity test because the COA looks complete; every source above keeps an identity or visual check with the receiver.
- Accepting a repacker’s certificate with no reference to the original manufacturer or original batch.
- Relying on a supplier before qualification or re-confirmation is recorded.
- Using non-certified reference-material values as if they were certified.
Sources
- 21 CFR 211.84, Testing and approval or rejection of components, drug product containers, and closures: https://www.law.cornell.edu/cfr/text/21/211.84
- 21 CFR 111.75, Determining whether specifications are met (dietary supplements): https://www.law.cornell.edu/cfr/text/21/111.75
- 21 CFR 211.180, General requirements (records): https://www.law.cornell.edu/cfr/text/21/211.180
- ICH Q7, GMP Guidance for Active Pharmaceutical Ingredients (FDA-hosted): https://fda.gov/media/71518/download
- WHO model certificate of analysis (TRS annex 4): WHO model CoA PDF
- NIST SRM definitions: https://www.nist.gov/srm/srm-definitions
COA Recordkeeping
Because a COA is the documented evidence behind a lot-release decision, it becomes part of the batch or lot record and is subject to the same retention and data-integrity expectations as other quality records under a GMP or ISO-based quality management system — attributable, legible, contemporaneous, original, and accurate (the ALCOA+ data-integrity principles commonly applied by regulators and auditors). Retention periods should follow the organization’s document-control procedure and any applicable regulatory minimum rather than a single fixed default.
For GMP-regulated material the minimum is set out in 21 CFR 211.180, and it is more specific than the “tied to shelf life” shorthand suggests:
- 211.180(a) – any production, control or distribution record specifically associated with a batch of a drug product must be retained for at least one year after the expiration date of the batch; for certain OTC drug products that lack expiration dating because they qualify for the exemption under 211.137, the period is instead three years after distribution of the batch.
- 211.180(b) – records for components, drug product containers, closures and labeling, which is the category a supplier COA falls into, must be kept for at least one year after the expiration date, or, for those same exempt OTC products, three years after distribution of the last lot of drug product that incorporated the component. That last clause is the one that catches firms out: the clock runs from the final product that used the component, not from the date the component was received.
- 211.180(c) – records must be readily available for authorized inspection at the establishment where the activities they describe occurred, throughout the retention period, and must be capable of being photocopied or otherwise reproduced during that inspection. Records retrievable immediately from another location by computer or other electronic means satisfy this, which is what makes a centralized electronic document system acceptable; an archive that takes days to recall from off-site storage does not.
- 211.180(d) – records may be kept as originals or as true copies such as photocopies, microfilm or microfiche, provided suitable reading and copying equipment is readily available.
Outside the GMP context the driver is different: an ISO/IEC 17025-accredited laboratory retains supplier certificates for reference materials and reagents for as long as its own accredited results depend on them being defensible, and an ISO 9001 organization sets the period in its own documented information controls. Neither imposes the 21 CFR 211.180 numbers, so a lab operating under both frameworks should not assume the pharmaceutical minima apply to it, nor that its own shorter default is adequate for any GMP-regulated work it takes on.
Frequently Asked Questions
Is a Certificate of Analysis legally required?
Requirements depend on the material and the regulatory framework governing its use. GMP-regulated pharmaceutical components fall under 21 CFR 211.84’s testing-and-approval requirements in the U.S.; many other materials (general lab reagents, non-regulated chemicals) have no independent legal mandate for a COA, but most reputable suppliers issue one as standard practice, and most quality management systems (ISO 9001, ISO/IEC 17025, ISO 13485) require some form of documented incoming verification for which a COA is common supporting evidence.
What’s the difference between a COA and a Certificate of Conformance (CoC)?
A COA reports the actual test results obtained for a specific parameter against its specification. A CoC is a shorter statement that a lot conforms, generally without the underlying data. A COA is the more informative document for verification purposes.
Does a COA guarantee the material is sterile or safe to use?
Only for whatever parameters it actually reports on. A COA that doesn’t include a sterility or endotoxin result says nothing about sterility, regardless of how complete the rest of the document looks — always check which specific tests were run, not just that testing happened.
Can a COA be trusted without any further verification?
Not in a GMP, ISO/IEC 17025, or ISO 9001 context. Regulators and accreditation bodies expect documented, risk-based verification beyond simply filing the supplier’s paperwork — see “When a Supplier COA Is Not Enough” above.
How long should a COA be retained?
Follow your organization’s document-control procedure and any applicable regulatory minimum retention period; for GMP-regulated components this is typically tied to the shelf life of the finished product the component went into, plus an additional defined period, not a single universal number.
What is the difference between a COA and a calibration certificate?
A COA reports lot-specific test results for a material against its specification. A calibration certificate documents the calibration of an instrument or reference standard and its traceability; see the guide to calibration certificates and metrological traceability.
Who signs and issues a Certificate of Analysis?
A Certificate of Analysis is issued by the manufacturer or supplier’s quality control laboratory and signed by an authorized QC/QA reviewer who approved that specific lot for release; an unsigned or undated COA has no accountable approver behind it and should be treated as incomplete. See the required-fields section above for the full signature and approval requirement.
Does every new lot need its own Certificate of Analysis?
Yes. A Certificate of Analysis is a lot-specific quality record, not a generic product datasheet — a COA for one lot describes only that lot, and receiving a different lot number always requires its own matching COA, verified by cross-checking the lot number on the paperwork against the lot number on the physical container.
What is the difference between a COA and a product specification sheet?
A product specification sheet (or datasheet) describes the general, expected properties of a product across all lots; a Certificate of Analysis reports the actual test results measured for one specific lot against that specification. A specification sheet tells you what should be true in general; a COA tells you what was actually measured for the material in hand.
What should you do if a shipment arrives without a Certificate of Analysis?
Keep the material in quarantine and segregate it so it cannot be drawn into use, then request the lot-specific document from the supplier against the purchase order, catalog number and the lot number on the container – or retrieve it yourself from the supplier’s lot-lookup portal if one exists. Record the discrepancy in the receiving record either way. Under 21 CFR 211.84(a), GMP-regulated components are withheld from use until sampled, tested or examined and released by the quality control unit, so quarantine is the default state of received material rather than an exceptional measure.
What if the COA arrives with the wrong lot number on it?
Treat it exactly as a missing COA. A certificate for a different lot is not evidence about the material in front of you, however complete it looks and however clearly it identifies the right product. Lot-number mismatch is the most common COA verification failure found in supplier audits, which is why matching the lot number on the paperwork to the lot number on the physical container is the first step of the verification checklist rather than a formality.
What happens if a COA result is out of specification?
If the result falls outside the supplier’s own specification, the lot should not have been released; 21 CFR 211.84(e) requires that a lot failing the appropriate written specifications be rejected. If the result is inside the supplier’s specification but outside yours – the more common case – it is a nonconformity against your requirement and needs raising and dispositioning as one, not accepting on the strength of the supplier’s conformance statement. Either way the disposition belongs in a documented nonconformance record with a named owner and a decision.
How long must a Certificate of Analysis be kept under 21 CFR 211.180?
Records for components, containers, closures and labeling must be retained for at least one year after the expiration date, or three years after distribution of the last lot of drug product incorporating the component for certain OTC products that lack expiration dating under the 211.137 exemption. The records must stay readily available for authorized inspection at the establishment where the activities occurred, and must be reproducible during that inspection; immediate electronic retrieval from another location counts.
Does a Certificate of Conformance satisfy the identity-testing requirement?
No. A CoC states that a lot conforms without reporting the underlying results, and neither a CoC nor a full COA removes the obligation under 21 CFR 211.84(d)(1) to conduct at least one test verifying the identity of each component. Supplier documentation can substitute for the rest of your testing only where you also conduct that specific identity test on the lot and have established the reliability of the supplier’s analyses through appropriate validation of their test results at appropriate intervals.
Regulatory text verified 23 August 2026 against the current eCFR for 21 CFR 211.84 and 21 CFR 211.180. Retention periods and testing obligations outside the U.S. GMP framework differ; confirm against the regulation or accreditation standard that governs your own operation.
Data: What each GMP/quality source says about relying on a supplier's certificate of analysis
Compares, across five regulatory or guidance sources, the minimum check retained by the receiving party, whether a supplier certificate can replace other testing, the supplier-validation condition, and the CoA content stated. Compiled from the primary texts of 21 CFR 211.84, 21 CFR 111.75, ICH Q7 (FDA-hosted text) and the WHO model certificate of analysis annex.
Period covered: Current texts as of 2026-11-14. Coverage: United States; international guidance.
| Source and scope | Minimum own test or check by receiver | Supplier certificate may replace other testing? | Condition on supplier reliability | Stated CoA content requirement |
|---|---|---|---|---|
| 21 CFR 211.84(d)(2), drug-product components | At least one specific identity test | Yes, for conformity with purity, strength and quality specifications (report of analysis) | Manufacturer establishes reliability of supplier analyses through appropriate validation at appropriate intervals | Not specified in this paragraph |
| 21 CFR 211.84(d)(3), containers and closures | At least visual identification | Yes (certificate of testing) | Manufacturer establishes reliability of supplier test results; validated at appropriate intervals | Not specified in this paragraph |
| 21 CFR 111.75(a), dietary supplement components | At least one appropriate identity test for any dietary-ingredient component | Yes, for other components (certificate of analysis) | Supplier qualified first by confirming reliability; records kept; periodic re-confirmation; QC approves qualification basis | Describes test or examination methods, test limits and actual results |
| ICH Q7 7.3 (APIs), incoming materials | At least one identity test per batch of material | Yes, if manufacturer has a system to evaluate suppliers | Complete analyses on at least three batches before reducing in-house testing; complete analysis at appropriate intervals compared with CoAs; reliability checked at regular intervals | Section 11.4 (for API/intermediate CoAs): name and grade, batch number, release date, expiry or retest date, tests with limits and numerical results, dated signature of quality-unit personnel, original manufacturer name, address and telephone |
| WHO model CoA (TRS Annex 4), QC laboratories | Not a receiving rule; model for issuing laboratories | Not addressed | Not addressed | Issuing lab name and address, CoA ID and page x of y, sample and batch details, original manufacturer, specifications with test procedure references, results versus limits, conclusion, dated signature; ISO/IEC 17025 accreditation reference where related to the analysis |
Sources
- 21 CFR 211.84 Testing and approval or rejection of components, drug product containers, and closures (accessed 2026-11-14)
- 21 CFR 111.75 What must you do to determine whether specifications are met (dietary supplements) (accessed 2026-11-14)
- ICH Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients (FDA) (accessed 2026-11-14)
- WHO Model certificate of analysis (TRS Annex 4) (accessed 2026-11-14)
Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.







